Phathom Pharmaceuticals Announces Vonoprazan NDA Submission for Non-Erosive GERD
September 26, 2023 08:01 ET
|
Phathom Pharmaceuticals
Submission based on positive results from Phase 3 PHALCON-NERD-301 in which vonoprazan 10 mg and 20 mg controlled heartburn symptoms through the entire 6 months of the study with a safety profile...
Protein Characterization and Identification Market Size Envisions USD 31.47 Billion by 2030, Exploring the 10.70% CAGR | Advancing Life Sciences
September 18, 2023 10:45 ET
|
Zion Market Research
New York, NY, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Market Research has published a new research report titled “Protein Characterization And Identification Market By Product & Services (Consumable,...
NurExone Moves Forward Towards Human Clinical Trials, Completes Pre-IND Meeting with the FDA for Proprietary ExoPTEN Drug
September 13, 2023 08:30 ET
|
NurExone Biologic Inc
The FDA’s response indicated that the planned toxicity study strategy is acceptable under FDA guidelines and large-scale animal studies will not be required. The completed Pre-IND meeting with the...
Protein Industries Canada and Innovate UK Announce Joint Call for Plant-Based Food and Ingredient R&D Projects
September 12, 2023 12:00 ET
|
Protein Industries Canada
Edmonton, Alta., Sept. 12, 2023 (GLOBE NEWSWIRE) -- The bilateral partnership between Protein Industries Canada, one of Canada’s five Global Innovation Clusters, and Innovate UK, the UK’s national...
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
September 05, 2023 08:00 ET
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
Final Reminder for Nano Dimension Shareholders to Vote FOR Its Highly Qualified Director Nominees
August 31, 2023 06:30 ET
|
Nano Dimension Ltd.
Final Deadline to Vote is 12:00 p.m. ET TODAY – Shareholders Must Call Their Brokers IMMEDIATELY to Ensure Their Vote is Counted! To Learn More About Nano’s Strategy and How to Vote:...
Foundery Launches Inaugural Biotech Venture Creation Fund to Accelerate the Development of Novel Immunotherapies
August 22, 2023 07:30 ET
|
Foundery Innovations
SAN FRANCISCO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Foundery, a biotechnology venture studio focused on translating immunology discoveries into drug candidates, today announced an initial closing of...
New Sericulture Experts Join Kraig Biocraft Laboratories, Bringing Extensive Experience Supporting Acceleration of Production Ramp-Up
July 19, 2023 07:05 ET
|
Kraig Biocraft Laboratories
ANN ARBOR, Mich., July 19, 2023 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and...
ITRI Celebrates Golden Jubilee: 50 Years of Empowering Industry through Innovations
July 14, 2023 01:15 ET
|
Industrial Technology Research Institute (ITRI)
HSINCHU, Taiwan, July 14, 2023 (GLOBE NEWSWIRE) -- ITRI celebrated its historic 50th anniversary on July 5. Taiwan President Tsai Ing-wen attended the anniversary ceremony and commended the...
Microchip Launches $300M Multi-Year Investment Initiative to Expand its Presence in India
July 03, 2023 07:30 ET
|
Microchip Technology Inc.
CHANDLER, Ariz., July 03, 2023 (GLOBE NEWSWIRE) -- Microchip Technology Incorporated (Nasdaq: MCHP), a leading provider of smart, connected and secure embedded control solutions, today announces a...